EUVIMEDEUVIMED entdecken
Crossref

Prediction of Small-Molecule Developability Using Large-Scale In Silico ADMET Models

Maximilian Beckers iD, Noé Sturm, Finton Sirockin iD, Nikolas Fechner iD, Nikolaus Stiefl iD

Journal of Medicinal Chemistry · 26.10.2023 · 66 (20) · 14047-14060

DOI: 10.1021/acs.jmedchem.3c01083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 10.10.2023. Verfasst von Maximilian Beckers und 4 weiteren Autor:innen. Beteiligte Einrichtung: Novartis Institutes for BioMedical Research, Novartis Pharma AG, Postfach, 4002 Basel, Switzerland. Hauptthemen laut MEDLINE: Computer Simulation. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Novartis Institutes for BioMedical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early in silico assessment of the potential of a series of compounds to deliver a drug is one of the major challenges in computer-assisted drug design. The goal is to identify the right chemical series of compounds out of a large chemical space to then subsequently prioritize the molecules with the highest potential to become a drug. Although multiple approaches to assess compounds have been developed over decades, the quality of these predictors is often not good enough and compounds that agree with the respective estimates are not necessarily druglike. Here, we report a novel deep learning approach that leverages large-scale predictions of ∼100 ADMET assays to assess the potential of a compound to become a relevant drug candidate. The resulting score, which we termed bPK score, substantially outperforms previous approaches and showed strong discriminative performance on data sets where previous approaches did not.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Computer Simulation

Autor:innen und Institutionen

  • Novartis Institutes for BioMedical Research, Novartis Pharma AG, Postfach, 4002 Basel, Switzerland.

ORCID-Profile: Maximilian Beckers, Finton Sirockin, Nikolas Fechner, Nikolaus Stiefl

Förderung

  • Novartis Institutes for BioMedical Research

Zitieren

APA

Beckers, M., Sturm, N., Sirockin, F., Fechner, N., & Stiefl, N. (2023). Prediction of Small-Molecule Developability Using Large-Scale In Silico ADMET Models. Journal of Medicinal Chemistry, 66(20), 14047-14060. https://doi.org/10.1021/acs.jmedchem.3c01083

Vancouver

Beckers M, Sturm N, Sirockin F, Fechner N, Stiefl N. Prediction of Small-Molecule Developability Using Large-Scale In Silico ADMET Models. Journal of Medicinal Chemistry. 2023;66(20):14047-14060. doi:10.1021/acs.jmedchem.3c01083

BibTeX
@article{Beckers2023,
  author = {Beckers, Maximilian and Sturm, Noé and Sirockin, Finton and Fechner, Nikolas and Stiefl, Nikolaus},
  title = {Prediction of Small-Molecule Developability Using Large-Scale In Silico ADMET Models},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {20},
  pages = {14047--14060},
  doi = {10.1021/acs.jmedchem.3c01083}
}
Kostenlos starten →